107 related articles for article (PubMed ID: 29202377)
21. Prognostic value of preoperative seizure in adult glioblastoma: A systematic review and meta-analysis.
Chen K; Duan P; Jiang P
Asian J Surg; 2021 Jul; 44(7):994-995. PubMed ID: 33965323
[No Abstract] [Full Text] [Related]
22. Significance of the prognostic nutritional index in patients with glioblastoma: A retrospective study.
Zhou XW; Dong H; Yang Y; Luo JW; Wang X; Liu YH; Mao Q
Clin Neurol Neurosurg; 2016 Dec; 151():86-91. PubMed ID: 27816892
[TBL] [Abstract][Full Text] [Related]
23. The utilization of MGMT promoter methylation testing in United States hospitals for glioblastoma and its impact on prognosis.
Lee A; Youssef I; Osborn VW; Safdieh J; Becker DJ; Schreiber D
J Clin Neurosci; 2018 May; 51():85-90. PubMed ID: 29483008
[TBL] [Abstract][Full Text] [Related]
24. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
25. Potential risk factors for incident glioblastoma multiforme: the Honolulu Heart Program and Honolulu-Asia Aging Study.
Nelson JS; Burchfiel CM; Fekedulegn D; Andrew ME
J Neurooncol; 2012 Sep; 109(2):315-21. PubMed ID: 22588335
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for glioblastoma patients--a clinical population-based study.
Fekete B; Werlenius K; Örndal C; Rydenhag B
Acta Neurol Scand; 2016 Jun; 133(6):434-41. PubMed ID: 26358197
[TBL] [Abstract][Full Text] [Related]
27. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
28. Survival analysis for valproic acid use in adult glioblastoma multiforme: a meta-analysis of individual patient data and a systematic review.
Yuan Y; Xiang W; Qing M; Yanhui L; Jiewen L; Yunhe M
Seizure; 2014 Nov; 23(10):830-5. PubMed ID: 25066904
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysis.
Zhao H; Wang S; Song C; Zha Y; Li L
World J Surg Oncol; 2016 Oct; 14(1):261. PubMed ID: 27733166
[TBL] [Abstract][Full Text] [Related]
30. Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma.
Shin JY; Kizilbash SH; Robinson S; Uhm JH; Jatoi A
Am J Hosp Palliat Care; 2017 Aug; 34(7):650-653. PubMed ID: 27151973
[TBL] [Abstract][Full Text] [Related]
31. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
Konar SK; Bir SC; Maiti TK; Nanda A
J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
[TBL] [Abstract][Full Text] [Related]
32. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implications of epilepsy in glioblastomas.
Toledo M; Sarria-Estrada S; Quintana M; Maldonado X; Martinez-Ricarte F; Rodon J; Auger C; Salas-Puig J; Santamarina E; Martinez-Saez E
Clin Neurol Neurosurg; 2015 Dec; 139():166-71. PubMed ID: 26489387
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta-analysis.
Chen JR; Xu HZ; Yao Y; Qin ZY
Acta Neurol Scand; 2015 Nov; 132(5):310-22. PubMed ID: 25846813
[TBL] [Abstract][Full Text] [Related]
35. Initial cognitive impairment predicts shorter survival of patients with glioblastoma.
Bruhn H; Blystad I; Milos P; Malmström A; Dahle C; Vrethem M; Henriksson R; Lind J
Acta Neurol Scand; 2022 Jan; 145(1):94-101. PubMed ID: 34514585
[TBL] [Abstract][Full Text] [Related]
36. Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
Zacharia BE; DiStefano N; Mader MM; Chohan MO; Ogilvie S; Brennan C; Gutin P; Tabar V
J Neurooncol; 2017 Sep; 134(2):245-251. PubMed ID: 28551847
[TBL] [Abstract][Full Text] [Related]
37. The hedgehog antagonist HHIP as a favorable prognosticator in glioblastoma.
Chang L; Zhang P; Zhao D; Liu H; Wang Q; Li C; Du W; Liu X; Zhang H; Zhang Z; Jiang C
Tumour Biol; 2016 Mar; 37(3):3979-86. PubMed ID: 26482617
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of YKL-40 in Patients with Glioblastoma: a Systematic Review and Meta-analysis.
Qin G; Li X; Chen Z; Liao G; Su Y; Chen Y; Zhang W
Mol Neurobiol; 2017 Jul; 54(5):3264-3270. PubMed ID: 27090900
[TBL] [Abstract][Full Text] [Related]
39. Outcome and prognostic factors in adult cerebellar glioblastoma.
Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]